Latest Global Markets News

Page 26 of 42
BlackRock Investment Management announces an estimated 33.12 cents per unit distribution for its iShares Global High Yield Bond (AUD Hedged) ETF for the June 2025 period, predominantly sourced from foreign income. The detailed tax breakdown aims to assist investors, especially non-residents, in managing withholding tax obligations.
Claire Turing
Claire Turing
8 July 2025
BlackRock Investment Management has released the estimated distribution components for the iShares Core MSCI World ex Australia ESG ETF for the period ending 30 June 2025, outlining key income sources and tax implications for investors.
Claire Turing
Claire Turing
8 July 2025
Betashares Capital Ltd has released the estimated annual distribution components for its Global Sustainability Leaders ETF (ETHI) for the 2024-25 financial year, highlighting a complex mix of foreign income and capital gains.
Claire Turing
Claire Turing
8 July 2025
EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.
Ada Torres
Ada Torres
7 July 2025
Sparc Hydrogen, in partnership with the University of Adelaide, has won a $2.75 million Australian Government grant to advance its pioneering green hydrogen pilot plant. This funding underscores the commercial promise of its novel photocatalytic water splitting technology.
Maxwell Dee
Maxwell Dee
4 July 2025
Horseshoe Metals has secured crucial Direct Shipping Ore mining approval for its Horseshoe Lights Copper-Gold Project, setting the stage for imminent production and early revenue generation from high-grade copper stockpiles.
Maxwell Dee
Maxwell Dee
2 July 2025
Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.
Ada Torres
Ada Torres
2 July 2025
EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.
Ada Torres
Ada Torres
2 July 2025
BlackRock Investment Management (Australia) Limited has announced the Distribution Reinvestment Plan (DRP) prices for its suite of Australian-domiciled iShares ETFs for the June 2025 distribution period. The update includes detailed pricing across multiple funds and important investor compliance reminders.
Claire Turing
Claire Turing
1 July 2025
The WCM Quality Global Growth Fund – Active ETF (WCMQ) is set to pay a substantial FY2025 distribution, triggering an expected 15% price adjustment as it trades ex-distribution from July 1. Investors are urged to consider the Distribution Reinvestment Plan to stay fully invested.
Claire Turing
Claire Turing
1 July 2025
DroneShield has landed a $9.7 million contract package in Latin America, reinforcing its foothold in the region’s defence market with deliveries scheduled for late 2025.
Victor Sage
Victor Sage
30 June 2025
NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.
Ada Torres
Ada Torres
27 June 2025